The Federal Trade Commission (FTC) is seeking public comment on an application by Cardinal Health, which is requesting approval to sell former Cardinal Health nuclear pharmacy assets to Patient Care Infusion.

Cryoablation has been shown to be an effective form of treatment for ovarian cancer, and this freeze and destroy technique could offer an alternative to surgery or chemotherapy for patients whose disease is in the late stages and oligometastatic, according to research published in the Journal of Vascular and Interventional Radiology and presented at the 2012 International Symposium on Endovascular Therapy in Miami in January.

Men with localized prostate cancer may not be receiving curative therapy (CTx) in accordance with potential clinical benefit, as patients with a low likelihood to benefit have received increasingly aggressive treatment in recent years while patients in groups that are likely to benefit from CTx have not seen comparable increases in treatment, according to a research letter published in the Feb. 27 issue of Archives of Internal Medicine.

The American College of Cardiology (ACC) recently testified at the House Ways and Means Subcommittee on Health during a special hearing to explore how private sector payors are rewarding physicians who deliver high quality and efficient care. ACC CEO Jack Lewin, MD, discussed several of the quality improvement collaborations underway in cardiology and what lessons can be applied across the healthcare system to simultaneously reduce unnecessary readmissions, complications, testing, and ineffective spending.

Computer-aided detection (CAD) increased radiologist sensitivity for breast cancer 10 percent and produced a concomitant increase in the recall rate, according to an article published in the March issue of American Journal of Roentgenology.

The Colon Cancer Alliance and American College of Radiology (ACR) have called on Medicare to cover seniors for virtual colonoscopy (CT colonography).

Interventional oncology techniques are gaining traction with liver and prostate cancers, particularly when other therapies have not proven successful. However, redirecting the tide of conventional treatment represents a significant obstacle.

As the debate continues over the benefit of screening mammography for women aged 40 to 49, research from Swedish Cancer Institute in Seattle has found that breast cancers detected by mammography in this age group have a better prognosis than those detected by other means, according to a study published in the March issue of Radiology.